Skip to main content

Monocloncal antibody approved for hypercholesterolemia. Is it the next big thing after stains?

By

The U.S. Food and Drug Administration on Friday approved alirocumab, the first of a new class of injected, cholesterol-lowering drugs.

Alirocumab cuts levels of LDL cholesterol, and is one of a group of newly developed drugs called PCSK9 inhibitors. The molecule happens to be a monoclonal antibody.

Approved indications 
  • The drug is only approved for patients with heart disease and a history of heart attack or stroke "who require additional lowering of LDL cholesterol" in addition to taking a statin drug and adopting a healthy diet. 
  • Heterozygous familial hypercholesterolemia (HeFH), an inherited illness that causes people to have high levels of LDL in the blood. 
The video shows how this new class of drugs reduces LDL levels in blood. 

>
Labels:

Comments

Post a Comment

Popular posts from this blog

Classify Rx: privacy policy

By
  The page is used to inform app users regarding our policies with the collection, use, and disclosure of Personal Information if anyone decided to use our Service. We will not use or share your information with anyone except as described in this Privacy Policy   Information Collection and Use The app does not use third party services that may collect information used to identify you as of now.   Log Data We want to inform you that whenever you use our Service, in a case of an error in the app we may receive anonymized data and information from the appropriate platform.     Cookie Cookies are files with small amount of data that is commonly used an anonymous unique identifier. These are sent to your browser from the website that you visit and are stored on your device internal memory. This Service does not use these cookies explicitly.     Links to Other Sites   This Service may contain links to other sites. If you click on a third-party link, you will be direc
Post a Comment
Read more

Anatnomics: Privacy policy

By
The page is used to inform app users regarding our policies with the collection, use, and disclosure of Personal Information if anyone decided to use our Service. We will not use or share your information with anyone except as described in this Privacy Policy   Information Collection and Use The app does not use third party services that may collect information used to identify you as of now.   Log Data We want to inform you that whenever you use our Service, in a case of an error in the app we may receive anonymized data and information from the appropriate platform.     Cookie Cookies are files with small amount of data that is commonly used an anonymous unique identifier. These are sent to your browser from the website that you visit and are stored on your device internal memory. This Service does not use these cookies explicitly.   Links to Other Sites   This Service may contain links to other sites. If you click on a third-party link, you will be directed to t
Post a Comment
Read more